Congress Wealth Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.03M Buy
31,103
+4,193
+16% +$333K 0.03% 491
2025
Q1
$1.99M Buy
26,910
+16,235
+152% +$1.28M 0.02% 493
2024
Q4
$771K Buy
10,675
+1,625
+18% +$123K 0.01% 559
2024
Q3
$739K Buy
9,050
+1,650
+22% +$143K 0.01% 567
2024
Q2
$789K Buy
7,400
+780
+12% +$74.8K 0.01% 465
2024
Q1
$643K Sell
6,620
-730
-10% -$64.2K 0.01% 423
2023
Q4
$576K Buy
7,350
+1,210
+20% +$82.5K 0.01% 448
2023
Q3
$385K Sell
6,140
-250
-4% -$16.4K 0.01% 492
2023
Q2
$411K Sell
6,390
-270
-4% -$15.2K 0.01% 442
2023
Q1
$353K Sell
6,660
-290
-4% -$14.2K 0.01% 464
2022
Q4
$292K Buy
6,950
+370
+6% +$15.5K 0.01% 484
2022
Q3
$241K Hold
6,580
0.01% 499
2022
Q2
$281K Sell
6,580
-70
-1% -$3.33K 0.01% 486
2022
Q1
$357K Sell
6,650
-430
-6% -$25K 0.01% 481
2021
Q4
$510K Buy
+7,080
New +$444K 0.01% 462

Other funds holding LRCX

Congress Wealth Management's LRCX Position: Q2 2025 in Review

Congress Wealth Management increased its Lam Research (LRCX) stake by 16% in Q2 2025, buying an estimated $333K and bringing the position to 31,103 shares worth $3.03M. The position accounts for 0.03% of the portfolio, ranked #491.

Congress Wealth Management first reported a position in LRCX in Q4 2021 and has held it in 15 quarters since. 1,883 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.

  • Congress Wealth Management held 31,103 shares of Lam Research worth $3.03M as of Q2 2025.
  • Congress Wealth Management bought 4,193 Lam Research shares in Q2 2025, an estimated $333K.
  • Lam Research made up 0.03% of Congress Wealth Management's portfolio in Q2 2025, its #491 holding.
  • Congress Wealth Management first reported a position in Lam Research in Q4 2021 and has held it in 15 quarters since.
  • 1,883 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.